EMEA-001806-PIP03-18

Key facts

Invented name
Kyprolis
Active substance
carfilzomib
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0171/2019
PIP number
EMEA-001806-PIP03-18
Pharmaceutical form(s)
Intravenous use
Condition(s) / indication(s)
Treatment of Multiple Myeloma
Route(s) of administration
Powder for solution for infusion
Contact for public enquiries
Amgen Europe B.V

Tel.: +44 (0)1223 420305
E-mail: medinfointernational@amgen.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating